Inga Fröding

454 total citations
18 papers, 330 citations indexed

About

Inga Fröding is a scholar working on Clinical Biochemistry, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Inga Fröding has authored 18 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 8 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in Inga Fröding's work include Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Resistance in Bacteria (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Inga Fröding is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Resistance in Bacteria (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Inga Fröding collaborates with scholars based in Sweden, United States and Greece. Inga Fröding's co-authors include Christian G. Giske, Agata Turlej-Rogacka, Neil Woodford, Mark A. Toleman, Chowdhury M. Hasan, David M. Livermore, Timothy R. Walsh, Hong Fang, Måns Ullberg and Martin Vondracek and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Inga Fröding

15 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inga Fröding Sweden 10 225 109 100 90 84 18 330
Daniel R. Evans United States 11 233 1.0× 109 1.0× 79 0.8× 103 1.1× 126 1.5× 15 405
Wenzi Bi China 11 248 1.1× 94 0.9× 67 0.7× 70 0.8× 108 1.3× 15 344
Celeste Lucero Argentina 13 327 1.5× 153 1.4× 80 0.8× 81 0.9× 74 0.9× 25 424
Michelle Lowe South Africa 11 208 0.9× 88 0.8× 69 0.7× 57 0.6× 75 0.9× 18 285
Marta Fernández-Martínez Spain 11 165 0.7× 156 1.4× 72 0.7× 80 0.9× 78 0.9× 19 342
Encho Savov Bulgaria 12 217 1.0× 101 0.9× 50 0.5× 88 1.0× 113 1.3× 23 361
Trevor Winstanley United Kingdom 4 245 1.1× 99 0.9× 130 1.3× 64 0.7× 48 0.6× 4 348
Erika Kocsis Hungary 11 154 0.7× 72 0.7× 65 0.7× 85 0.9× 82 1.0× 18 299
Cindy Wing‐Sze Tse China 10 148 0.7× 78 0.7× 87 0.9× 98 1.1× 67 0.8× 19 260
Farouk Barguellil Tunisia 11 206 0.9× 102 0.9× 65 0.7× 70 0.8× 76 0.9× 24 291

Countries citing papers authored by Inga Fröding

Since Specialization
Citations

This map shows the geographic impact of Inga Fröding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Fröding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Fröding more than expected).

Fields of papers citing papers by Inga Fröding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga Fröding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Fröding. The network helps show where Inga Fröding may publish in the future.

Co-authorship network of co-authors of Inga Fröding

This figure shows the co-authorship network connecting the top 25 collaborators of Inga Fröding. A scholar is included among the top collaborators of Inga Fröding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga Fröding. Inga Fröding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Papaparaskevas, Joseph, Erika Matuschek, Tara Wahab, et al.. (2025). Defining epidemiological cutoff values for Brucella melitensis: an European multicentre study. Clinical Microbiology and Infection. 32(1). 95–101.
4.
Fröding, Inga, et al.. (2023). Analytical Performance and Potential Clinical Utility of EUCAST Rapid Antimicrobial Susceptibility Testing in Blood Cultures after Four Hours of Incubation. Microbiology Spectrum. 11(2). e0500122–e0500122. 6 indexed citations
5.
Tryfinopoulou, Kyriaki, Marius Linkevičius, Όλγα Παππά, et al.. (2023). Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 to 2022. Eurosurveillance. 28(47). 21 indexed citations
6.
Fang, Hong, Inga Fröding, Måns Ullberg, & Christian G. Giske. (2020). Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in Stockholm, Sweden. Journal of Hospital Infection. 107. 12–15. 15 indexed citations
8.
Giske, Christian G., et al.. (2019). Transmission events and antimicrobial susceptibilities of methicillin-resistant Staphylococcus argenteus in Stockholm. Clinical Microbiology and Infection. 25(10). 1289.e5–1289.e8. 20 indexed citations
9.
Fröding, Inga, et al.. (2019). Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis. International Journal of Antimicrobial Agents. 53(6). 820–829. 9 indexed citations
10.
Samuelsson, Anders, et al.. (2019). Surface Contamination of CT and MRI Equipment—A Potential Source for Transmission of Hospital-Acquired Infections. Journal of Radiology Nursing. 38(4). 254–260. 4 indexed citations
11.
Fröding, Inga, Christian G. Giske, Karolina Ininbergs, et al.. (2018). USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016. PLoS ONE. 13(11). e0205761–e0205761. 19 indexed citations
12.
Fröding, Inga, et al.. (2018). Oral microbiology in the microbiome era - when, how and why to perform microbiological diagnostics. ˜Den œNorske tannlegeforenings tidende. 118(11). 908–13. 1 indexed citations
14.
Fröding, Inga, Martin Vondracek, & Christian G. Giske. (2016). Rapid EUCAST disc diffusion testing of MDREscherichia coliandKlebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation. Journal of Antimicrobial Chemotherapy. 72(4). dkw515–dkw515. 25 indexed citations
15.
Fröding, Inga & Marika Hjertqvist. (2014). [Severe TBE with sequelae can also affect young children. Vaccination advice to children should be individualized, degree of exposure essential].. PubMed. 110(42). 1861–4. 2 indexed citations
16.
Fröding, Inga, et al.. (2014). [Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection].. PubMed. 111(9-10). 396–8. 2 indexed citations
17.
Giske, Christian G., Inga Fröding, Chowdhury M. Hasan, et al.. (2012). Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination of bla NDM-1 in India, Sweden, and the United Kingdom. Antimicrobial Agents and Chemotherapy. 56(5). 2735–2738. 161 indexed citations
18.
Blennow, Ola, Katarina Westling, Inga Fröding, & Volkan Özenci. (2011). Pneumonia and Bacteremia Due to Kytococcus schroeteri. Journal of Clinical Microbiology. 50(2). 522–524. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026